Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Non-cash Items (2019 - 2025)

Cyclerion Therapeutics has reported Non-cash Items over the past 7 years, most recently at $251301.0 for Q2 2025.

  • Quarterly results put Non-cash Items at $251301.0 for Q2 2025, changed 0.35% from a year ago — trailing twelve months through Jun 2025 was $251301.0 (changed 0.35% YoY), and the annual figure for FY2022 was $5.3 million, up 16.91%.
  • Non-cash Items for Q2 2025 was $251301.0 at Cyclerion Therapeutics, down from $259911.0 in the prior quarter.
  • Over the last five years, Non-cash Items for CYCN hit a ceiling of $5.4 million in Q3 2022 and a floor of $20000.0 in Q4 2022.
  • Median Non-cash Items over the past 5 years was $252429.0 (2024), compared with a mean of $1.7 million.
  • Biggest five-year swings in Non-cash Items: skyrocketed 2580.67% in 2022 and later tumbled 94.88% in 2023.
  • Cyclerion Therapeutics' Non-cash Items stood at $200000.0 in 2021, then plummeted by 90.0% to $20000.0 in 2022, then surged by 1186.07% to $257214.0 in 2023, then fell by 1.86% to $252429.0 in 2024, then fell by 0.45% to $251301.0 in 2025.
  • The last three reported values for Non-cash Items were $251301.0 (Q2 2025), $259911.0 (Q1 2025), and $252429.0 (Q3 2024) per Business Quant data.